{"pub": "marketwatch", "url": "https://marketwatch.com/story/fresenius-profit-and-sales-grow-as-company-backs-outlook-2019-10-29", "downloaded_at": "2019-10-29 07:45:15.105149+00:00", "title": "Fresenius profit and sales grow as company backs outlook", "language": "en", "text": "Fresenius SE & Co. KGaA said Tuesday that net profit and sales both rose in the third quarter, and backed its full-year outlook.\n\nNet income was 444 million euros ($492.4 million), up from EUR419 million in the previous-year period, while sales grew 7.9% to EUR8.42 billion.\n\nThe German provider of health products and services FRE, +1.62% backed its earnings guidance for 2019. The company sees sales growth at constant currency rates of between 4% to 7%, while net income on a comparable basis is expected to be flat.\n\nAt Fresenius Medical Care (FME.XE), the company\u2019s dialysis division, net profit rose 17% to EUR333 million, while sales increased by 8.9% to EUR4.42 billion.", "description": "The German provider of health products and services\u00a0backed its earnings guidance for 2019.", "authors": ["Carlo Martuscelli"], "top_image": "https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png", "published_at": "2019-10-29"}